Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.07
-$0.16 (-13.01%)
At close: Oct 30, 2026, 4:00 PM ET
$1.08
+$0.01 (+0.96%)
Pre-market:
Nov 2, 2026, 8:39 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | -1.84M | -1.27M | n/a | 3.32M | 4.7M | 5.37M |
Cost of Revenue | 8.52M | 8.52M | 8.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -8.52M | -8.52M | -8.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | -1.84M | -1.27M | n/a | 3.32M | 4.7M | 5.37M |
Operating Income | -14.84M | -13.18M | -12.61M | -5.07M | -5.18M | -5.68M | -5.73M | -5.22M | -6.74M | -9.25M | -12.89M | -18.4M | -21.49M | -22.28M | -22.98M | -20.64M | -18.77M | -17.13M | -12.81M | -10.43M | -8.44M | -7.04M |
Interest Income | 71.8K | 49.95K | n/a | 63.35K | 76.03K | 111.38K | 158.54K | 222.66K | 277.68K | 328.69K | 352.25K | 368.41K | 357.64K | 303.19K | 231.3K | 126.24K | 48.12K | 8.76K | 752 | 752 | 265 | 304 |
Pretax Income | -14.45M | -13.03M | -12.52M | -5M | -5.1M | -5.57M | -5.58M | -4.99M | -6.46M | -8.92M | -12.54M | -18.03M | -30M | -30.84M | -31.61M | -29.34M | -18.67M | -17.03M | -12.77M | -10.43M | -8.41M | -7.12M |
Net Income | -14.45M | -13.03M | -12.52M | -5M | -5.1M | -5.57M | -5.58M | -4.99M | -6.46M | -8.92M | -12.54M | -18.03M | -30M | -30.84M | -31.61M | -29.34M | -18.67M | -17.03M | -12.77M | -10.43M | -8.41M | -7.12M |
Selling & General & Admin | 4.1M | 3.62M | 3.73M | 4.64M | 4.67M | 5.08M | 4.96M | 4.56M | 5.19M | 5.55M | 5.72M | 6.6M | 6.94M | 7.16M | 7.14M | 6.8M | 6.69M | 6.45M | 6.1M | 5.87M | 5.47M | 5.58M |
Research & Development | 2.23M | 1.04M | 368.17K | 429.09K | 504.49K | 602.56K | 770.03K | 654.63K | 1.55M | 3.69M | 7.17M | 11.8M | 14.55M | 15.12M | 15.84M | 13.85M | 12.07M | 11.25M | 8.55M | 7.88M | 7.66M | 7.01M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.84M | -1.84M | -1.84M | -1.84M | 440 | 440 | -178.59K |
Operating Expenses | 6.33M | 4.66M | 4.1M | 5.07M | 5.18M | 5.68M | 5.73M | 5.22M | 6.74M | 9.25M | 12.89M | 18.4M | 21.49M | 22.28M | 22.98M | 18.8M | 16.93M | 15.86M | 12.81M | 13.74M | 13.14M | 12.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25K | 4.04K | 7.27K | 7.27K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.84M | 13.18M | 12.61M | 5.07M | 5.18M | 5.68M | 5.73M | 5.22M | 6.74M | 9.25M | 12.89M | 18.4M | 21.49M | 22.28M | 22.98M | 18.8M | 16.93M | 15.86M | 12.81M | 13.74M | 13.14M | 12.41M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 531.97K | 531.97K | 481.59K | 481.59K | 141.52K | 110.93K | 96.08K | 85.46K | 40.03K | 34.96K | 32.82K | 31.28K | 22.58K | 19.93K | 18.78K | 18.73K | 17.84K | 15.5K | 15.08K | 14.93K | 14.92K | 10.92K |
Shares Outstanding (Diluted) | 531.97K | 531.97K | 481.59K | 481.59K | 141.52K | 110.93K | 96.08K | 85.46K | 40.03K | 34.96K | 32.82K | 31.28K | 22.58K | 19.93K | 18.78K | 18.73K | 17.84K | 15.5K | 15.08K | 14.93K | 14.92K | 10.92K |
EPS (Basic) | -29.09 | -31.40 | -42.63 | -39.23 | -48.79 | -77.61 | -111.27 | -122.90 | -189.61 | -325.77 | -544.64 | -857.02 | -1.55K | -1.64K | -1.77K | -1.7K | -1.18K | -1.12K | -898.12 | -880.96 | -917.32 | -1.09K |
EPS (Diluted) | -29.09 | -31.40 | -42.63 | -39.23 | -48.79 | -77.61 | -111.27 | -122.90 | -189.61 | -325.77 | -544.64 | -857.02 | -1.55K | -1.64K | -1.77K | -1.7K | -1.18K | -1.12K | -898.12 | -880.96 | -917.32 | -1.09K |
EBITDA | -14.44M | -13.02M | -12.51M | -5M | -5.1M | -5.57M | -5.57M | -4.99M | -6.46M | -8.91M | -12.53M | -18.02M | -29.99M | -30.84M | -31.6M | -29.33M | -18.66M | -17.01M | -12.7M | -10.35M | -8.38M | -7.02M |
EBIT | -14.45M | -13.03M | -12.52M | -5M | -5.1M | -5.57M | -5.58M | -4.99M | -6.46M | -8.92M | -12.54M | -18.03M | -30M | -30.84M | -31.61M | -29.34M | -18.67M | -17.03M | -12.72M | -10.37M | -8.4M | -7.04M |
Depreciation & Amortization | 10.86K | 11.97K | 7.15K | 4.42K | 4.42K | 4.42K | 4.42K | 4.42K | 8.93K | 9.49K | 10.05K | 10.62K | 6.68K | 3.55K | 6.68K | 9.8K | 12.93K | 19.19K | 19.18K | 19.75K | 19.18K | 18.62K |
Add to Watchlist
Select watchlists to add or remove DCOY